RBC Balanced Immuno-inflammatory Signatures Identify Advanced Breast Cancer Patients on CDK4/6 Inhibitors at Increased Risk of Progression and Death
收藏Mendeley Data2026-04-09 收录
官方服务:
资源简介:
This is the serum metabolomics data of hormone receptor positive advanced cancer patients before receiving CDK4/6 inhibitor treatment. The code for analysis is attached.




